Recent data from cancer cells revealed the enzyme preference for cell cycle-dependent promoters characterized by the E2F motifs, the presence of CpG islands, and the occurrence of BRG1-based SWI/SNF complexes, but PARP1 acted as an activator once all these features were followed by histone acetylation [135]. The gene discussed is SMARCA4; the disease is cancer.